Pharmaceutical Business review

ONCOlog Medical and C-RAD collaborate in radiotherapy

The two Swedish companies, ONCOlog Medical and C-RAD, offer technical solutions that quickly and exactly position patients and thereafter monitor the positioning during treatment. The aim of their strategic collaboration is to minimize the need for CT/MR-simulation before radiotherapy, as well as for individual fixation equipment. The collaboration facilitates new and efficient solutions that combine ONCOlog Medical’s PatLog Load and SteroLog with C-RAD’s Sentinel.

Hans Dahlin, CEO of ONCOlog Medical, said: “The companies’ complementing products for patient positioning ensures safer and more efficient radiation therapy, something that is high on the agenda at radiation clinics all over the world.”

Exit mobile version